Wei Li

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

Robert I. Haddad, Kevin J. Harrington, Makoto Tahara et al. · Journal of Clinical Oncology · 2022 · 142 citations · Full text

Kaempferol induces apoptosis in human HCT116 colon cancer cells via the Ataxia-Telangiectasia Mutated-p53 pathway with the involvement of p53 Upregulated Modulator of Apoptosis

Wei Li, Bingna Du, Tianyi Wang et al. · Chemico-Biological Interactions · 2008 · 98 citations

Ataxia-telangiectasia Mutated-p53 Pathway, Oncology, Oncogenic Agent +9

Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141

Maura L. Gillison, George R. Blumenschein, Jérôme Fayette et al. · The Oncologist · 2022 · 47 citations · Full text

Neck Cancer, Nivolumab Versus Ic, Cancer Management +16

MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma

Zhuochao Liu, Junxiang Wen, Chuanlong Wu et al. · Aging · 2020 · 34 citations · Full text

<p>Potential Diagnostic Value Of Combining Inflammatory Cell Ratios With Carcinoembryonic Antigen For Colorectal Cancer</p>

Xinxin Li, Dongming Guo, Ling‐Yu Chu et al. · Cancer Management and Research · 2019 · 31 citations · Full text